Kolon Life Science Inc. (KOSDAQ:102940)
South Korea
· Delayed Price · Currency is KRW 59,200
-1,800 (-2.95%)
Apr 29, 2026, 12:08 PM KST
Kolon Life Science Revenue
In the year 2025, Kolon Life Science had annual revenue of 208.98B KRW with 29.49% growth. Kolon Life Science had revenue of 44.72B in the quarter ending December 31, 2025, a decrease of -4.59%.
Revenue
208.98B
Revenue Growth
+29.49%
P/S Ratio
3.82
Revenue / Employee
491.72M
Employees
425
Market Cap
798.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 208.98B | 47.59B | 29.49% |
| Dec 31, 2024 | 161.39B | 36.75B | 29.48% |
| Dec 31, 2023 | 124.64B | -36.94B | -22.86% |
| Dec 31, 2022 | 161.58B | -3.90B | -2.36% |
| Dec 31, 2021 | 165.49B | 36.07B | 27.87% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TKG Huchems | 1,127.69B |
| Miwon Commercial | 441.14B |
| UNID Company | 1,338.76B |
| ENF Technology | 670.90B |
| Kumyang | 102.78B |
| Miwon Specialty Chemical | 532.12B |
| Korea Petrochemical Ind. | 3,347.82B |
| Taekwang Industrial | 1,827.44B |